American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative182
Economic Burden of Chronic Hand Eczema: A Review152
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions145
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review101
Prognostic Biomarkers in Evolving Melanoma Immunotherapy90
The Current State of Systemic Therapy of Metastatic Uveal Melanoma87
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments83
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments81
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review79
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know77
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study75
The Burden of Pediatric Psoriasis: A Systematic Review73
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?58
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology57
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution56
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi55
Pathophysiology of Generalized Pustular Psoriasis54
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data54
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review53
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion53
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”51
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation51
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment49
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study48
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission48
Skin Cancer in People of Color: A Systematic Review45
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature44
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials44
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives43
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment42
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis40
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis40
A Practice Approach to Acne Fulminans in Adolescents40
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management39
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review38
Patient and Public Involvement in Dermatology Research: A Review37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates37
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm37
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist37
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis36
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review36
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases35
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options34
Oral Lichen Planus: An Update on Diagnosis and Management34
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa34
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching33
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”33
Individualized Neoantigen-Directed Melanoma Therapy33
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada32
Frontal Fibrosing Alopecia: An Update31
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists30
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential29
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials29
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study29
Targeting Inflammation in Acne: Current Treatments and Future Prospects27
Advancing Precision Medicine in Inflammatory Skin Disease27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)26
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History26
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”25
Acknowledgement to Referees25
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program25
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea25
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management24
Management of Acne in Pregnancy24
Identifying and Treating Ocular Manifestations in Psoriasis23
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results23
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year23
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis23
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study22
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study22
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review22
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients22
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians22
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials21
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey21
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 21
Approach to the Atypical Wound21
Safety of Hydroxychloroquine: What a Dermatologist Should Know20
Is There a Place for Biologics in Acne?20
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights20
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color19
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts19
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study18
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study18
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)18
An Update on New and Existing Treatments for the Management of Melasma18
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-218
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study18
0.063066959381104